Updated statistics show that it’s more than economic strength, charitable giving and religiosity that stand out.
Trial results indicate that in adults 65 years and older, the high-dose inactivated influenza vaccine (HD-IIV) consistently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback